Prevalence of the Clinical Symptoms and PCR Test Results on Patients With COVID-19 in South of Tehran
- PMID: 35903755
- PMCID: PMC9315899
- DOI: 10.1177/11786361221097680
Prevalence of the Clinical Symptoms and PCR Test Results on Patients With COVID-19 in South of Tehran
Abstract
Background: The first human case of COVID-19 was reported on 19 February 2020 in Iran, since then the number of infected cases has dramatically increased to about 1.800 million and about 62 000 deaths, also elderly people have accounted for the largest frequency of mortality.
Objective: This study aims to evaluate the prevalence of Covid-19 RT-PCR positive among Iranian patients and to evaluate the most important clinical symptoms of identified patients based on age, gender, and their background diseases to be used as an aid for early diagnosis.
Methods: During 9 months, swab samples of 11 034 patients' nasopharynx and oropharynx secretions were obtained and were referred to the laboratory for Covid-19 RT-PCR test. In addition, the history of signs and symptoms from patients was recorded.
Results: In total, 11 034 Covid-19 RT-PCR tests that performed, 3358 samples had positive results (30.4%). Headache was the most commonly reported, which was found in 42.5% of our cases. Fever was the second most common symptom among the patients studied, with a prevalence rate of 36.2%.
Conclusion: In this study, almost 30% of symptomatic patients had positive Covid-19 RT-PCR test results. Headache was the most common symptom; also diarrhea and nausea were the least common symptoms among patients under this study.
Keywords: COVID-19; RT-PCR; coronavirus; prevalence; symptoms.
© The Author(s) 2022.
Conflict of interest statement
Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Similar articles
-
Clinical and biochemical characteristics and outcomes of suspected COVID-19 hospitalized patients: RT-PCR swab positive and negative comparison.J Infect Public Health. 2021 Nov;14(11):1623-1629. doi: 10.1016/j.jiph.2021.09.014. Epub 2021 Sep 23. J Infect Public Health. 2021. PMID: 34624717 Free PMC article.
-
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1. Trials. 2021. PMID: 33849629 Free PMC article.
-
Delayed RT-PCR Time-To-Positivity in an adult with SARS-CoV-2 Infection.J Infect Dev Ctries. 2021 Jul 31;15(7):913-917. doi: 10.3855/jidc.14766. J Infect Dev Ctries. 2021. PMID: 34343115
-
The value of anal swab RT-PCR for COVID-19 diagnosis in adult Indonesian patients.BMJ Open Gastroenterol. 2021 May;8(1):e000590. doi: 10.1136/bmjgast-2020-000590. BMJ Open Gastroenterol. 2021. PMID: 34011623 Free PMC article.
-
COVID-19 - 6 million cases worldwide and an overview of the diagnosis in Brazil: a tragedy to be announced.Diagn Microbiol Infect Dis. 2020 Oct;98(2):115113. doi: 10.1016/j.diagmicrobio.2020.115113. Epub 2020 Jun 15. Diagn Microbiol Infect Dis. 2020. PMID: 32682217 Free PMC article. Review.
Cited by
-
Epidemiological situation of SARS-CoV-2 infection in Douala, the most populated and highly heterogeneous town of Cameroon: a post-vaccination update.Acta Trop. 2023 May;241:106864. doi: 10.1016/j.actatropica.2023.106864. Epub 2023 Feb 26. Acta Trop. 2023. PMID: 36849093 Free PMC article.
References
-
- China Wuhan Municipal Health Commission Wuhan Municipal Health Commission briefing on the pneumonia epidemic situation 31 Dec 2019. [in Chinese]. 2020. http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989
LinkOut - more resources
Full Text Sources